Provinces;Age ranges;Cohorts;Sex;Demographic Concepts;Periodo;Total
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.152.930
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;3.004.925
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;2.911.594
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,31
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,35
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.963.343
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;1.875.050
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;1.822.502
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,5
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,83
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.189.587
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;1.129.875
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;1.089.092
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,98
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,55
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.156.533
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;3.050.767
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,65
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.963.778
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;1.903.731
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,94
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.192.755
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;1.147.036
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,17
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;222.515
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;202.371
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;190.341
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90,95
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85,54
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;137.664
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;125.471
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;118.387
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91,14
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;84.851
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;76.900
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;71.954
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90,63
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84,8
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;200.747
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;187.336
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,32
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;125.663
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;117.588
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93,57
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;75.084
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;69.748
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,89
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;540.771
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;509.654
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;490.132
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,25
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,64
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;315.885
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;298.299
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;287.751
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,43
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,09
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;224.886
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;211.355
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;202.381
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,98
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,99
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;520.045
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;498.140
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,79
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;303.305
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;291.328
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,05
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;216.740
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;206.812
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,42
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;899.258
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;863.754
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;840.077
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,05
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,42
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;554.627
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;533.823
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;521.121
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,25
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,96
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;344.631
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;329.931
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;318.956
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,73
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,55
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;868.633
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;842.217
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,96
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;532.141
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;517.819
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,31
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;336.492
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;324.398
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,41
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;949.089
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;919.584
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;899.959
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,89
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,82
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;602.960
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;585.559
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;574.762
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,11
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,32
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;346.129
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;334.025
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;325.197
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,5
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,95
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;965.647
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;943.304
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,69
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;612.352
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;599.980
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,98
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;353.295
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;343.324
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,18
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;541.297
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;509.562
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;491.085
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,14
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,72
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;352.207
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;331.898
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;320.481
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,23
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,99
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;189.090
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;177.664
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;170.604
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,96
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,22
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;601.461
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;579.770
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,39
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;390.317
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;377.016
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,59
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;211.144
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;202.754
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,03
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;25.147
02 Albacete;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;24.144
02 Albacete;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;23.354
02 Albacete;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,01
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,87
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;16.407
02 Albacete;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;15.772
02 Albacete;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;15.352
02 Albacete;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,13
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,57
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;8.740
02 Albacete;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;8.372
02 Albacete;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;8.002
02 Albacete;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,79
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,56
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;25.111
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;24.234
02 Albacete;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,51
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;16.361
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;15.883
02 Albacete;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,08
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;8.750
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;8.351
02 Albacete;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,44
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.794
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1.652
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1.540
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92,08
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85,84
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.135
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1.041
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;986
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91,72
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86,87
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;659
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;611
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;554
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,72
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84,07
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.616
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;1.503
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,01
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.018
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;959
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94,2
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;598
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;544
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;90,97
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.160
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;3.971
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;3.814
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,46
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,68
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.538
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;2.435
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;2.349
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,94
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,55
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.622
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1.536
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1.465
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,7
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,32
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.932
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;3.760
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,63
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.405
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;2.311
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,09
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.527
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1.449
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,89
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;6.900
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;6.672
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;6.498
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,7
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,17
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.467
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;4.322
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;4.231
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,75
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,72
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.433
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2.350
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2.267
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,59
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,18
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;6.665
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;6.477
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,18
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.279
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;4.179
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,66
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.386
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2.298
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,31
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;7.797
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;7.595
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;7.419
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,41
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,15
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;5.189
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;5.057
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;4.973
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,46
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,84
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.608
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;2.538
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;2.446
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,32
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,79
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;7.807
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;7.613
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,52
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;5.172
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;5.074
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,11
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.635
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;2.539
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,36
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.496
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;4.254
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;4.083
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,62
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,81
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.078
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;2.917
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;2.813
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,77
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,39
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.418
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1.337
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1.270
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,29
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,56
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;5.091
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;4.881
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,88
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;3.487
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;3.360
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,36
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.604
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1.521
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,83
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;145.490
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;138.171
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;133.559
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,97
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,8
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;90.963
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;86.656
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;84.069
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,27
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,42
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;54.527
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;51.515
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;49.490
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,48
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,76
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;146.800
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;141.474
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,37
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;91.761
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;88.713
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,68
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;55.039
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;52.761
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,86
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;9.995
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;9.119
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;8.575
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91,24
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85,79
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;6.308
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;5.779
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;5.446
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91,61
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86,33
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.687
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;3.340
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;3.129
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90,59
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84,87
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;9.116
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;8.494
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,18
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;5.852
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;5.453
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93,18
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.264
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;3.041
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93,17
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;24.890
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;23.415
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;22.535
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,07
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,54
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;14.579
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;13.751
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;13.291
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,32
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,17
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;10.311
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;9.664
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;9.244
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,73
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,65
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;24.132
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;23.106
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,75
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;14.161
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;13.605
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,07
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;9.971
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;9.501
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,29
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;42.418
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;40.617
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;39.434
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,75
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,97
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;26.111
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;25.075
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;24.424
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,03
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,54
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;16.307
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;15.542
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;15.010
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,31
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,05
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;41.500
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;40.176
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,81
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;25.400
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;24.649
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,04
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;16.100
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;15.527
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,44
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;43.743
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;42.171
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;41.118
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,41
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;27.848
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;26.927
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;26.343
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,69
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,6
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;15.895
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;15.244
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;14.775
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,9
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,95
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;44.691
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;43.499
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,33
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;28.345
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;27.696
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,71
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;16.346
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;15.803
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,68
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;24.444
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;22.849
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;21.897
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,47
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89,58
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;16.117
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;15.124
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;14.565
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,84
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,37
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;8.327
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;7.725
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;7.332
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,77
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;88,05
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;27.361
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;26.199
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,75
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;18.003
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;17.310
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,15
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;9.358
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;8.889
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,99
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;42.797
04 Almería;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;40.828
04 Almería;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;39.549
04 Almería;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,4
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,41
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;26.219
04 Almería;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;25.071
04 Almería;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;24.360
04 Almería;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,62
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,91
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;16.578
04 Almería;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;15.757
04 Almería;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;15.189
04 Almería;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,05
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,62
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;42.953
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;41.511
04 Almería;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,64
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;26.303
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;25.493
04 Almería;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,92
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;16.650
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;16.018
04 Almería;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,2
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.320
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;3.061
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;2.898
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92,2
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;87,29
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.020
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1.871
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1.768
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92,62
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87,52
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.300
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1.190
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1.130
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;91,54
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86,92
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.047
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;2.851
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,57
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.890
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1.764
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93,33
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.157
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1.087
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93,95
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;7.690
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;7.270
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;7.004
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,54
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,08
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.450
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;4.227
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;4.085
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,99
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,8
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.240
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;3.043
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;2.919
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,92
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,09
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;7.397
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;7.110
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,12
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.294
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;4.129
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,16
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.103
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;2.981
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,07
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;12.723
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;12.212
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;11.846
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,98
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,11
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;7.716
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;7.435
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;7.234
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,36
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,75
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;5.007
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;4.777
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;4.612
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,41
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,11
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;12.288
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;11.897
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,82
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;7.410
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;7.203
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,21
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.878
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;4.694
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,23
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;12.283
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;11.914
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;11.658
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,91
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;7.676
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;7.455
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;7.325
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,12
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,43
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.607
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;4.459
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;4.333
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,79
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,05
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;12.570
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;12.268
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,6
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;7.835
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;7.677
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,98
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.735
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;4.591
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,96
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;6.781
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;6.371
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;6.143
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,95
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,59
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.357
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;4.083
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;3.948
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,71
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,61
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.424
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;2.288
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;2.195
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,39
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,55
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;7.651
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;7.385
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,52
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.874
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;4.720
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,84
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.777
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;2.665
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,97
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;18.166
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;17.396
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;16.928
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,76
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,19
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;11.166
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;10.680
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;10.432
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,65
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,43
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;7.000
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;6.716
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;6.496
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,94
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,8
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;18.077
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;17.555
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,11
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;11.103
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;10.815
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,41
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;6.974
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;6.740
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,64
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.142
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1.050
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;994
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91,94
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;87,04
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;701
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;643
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;614
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91,73
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87,59
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;441
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;407
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;380
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,29
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86,17
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.038
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;972
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,64
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;664
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;626
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94,28
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;374
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;346
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,51
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.696
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;2.549
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;2.452
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,55
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,95
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.539
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;1.447
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;1.401
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,02
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,03
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.157
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1.102
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1.051
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,25
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,84
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.610
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;2.503
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,9
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.479
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;1.426
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,42
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.131
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1.077
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,23
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.981
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;4.831
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;4.721
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,99
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,78
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.009
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;2.911
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;2.853
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,74
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,82
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.972
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;1.920
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;1.868
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,36
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,73
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.749
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;4.624
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,37
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.833
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;2.765
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,6
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.916
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;1.859
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,03
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;6.021
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;5.849
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;5.757
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,14
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,62
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.759
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;3.656
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;3.609
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,26
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96,01
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.262
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;2.193
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;2.148
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,95
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,96
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;6.053
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;5.956
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,4
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;3.759
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;3.710
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,7
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.294
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;2.246
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,91
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.326
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;3.117
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;3.004
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,72
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,32
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.158
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;2.023
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;1.955
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,74
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,59
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.168
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1.094
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1.049
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,66
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,81
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.627
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;3.500
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,5
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.368
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;2.288
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,62
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.259
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1.212
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,27
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;62.834
33 Asturias;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;60.182
33 Asturias;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;58.542
33 Asturias;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,78
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,17
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;36.994
33 Asturias;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;35.465
33 Asturias;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;34.627
33 Asturias;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,87
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,6
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;25.840
33 Asturias;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;24.717
33 Asturias;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;23.915
33 Asturias;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,65
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,55
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;62.715
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;60.868
33 Asturias;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,05
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;36.836
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;35.872
33 Asturias;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,38
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;25.879
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;24.996
33 Asturias;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,59
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.270
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;2.977
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;2.799
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91,04
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85,6
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.931
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1.768
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1.672
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91,56
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86,59
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.339
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1.209
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1.127
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90,29
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84,17
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.941
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;2.736
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,03
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.771
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1.659
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93,68
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.170
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1.077
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,05
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;9.256
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;8.799
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;8.506
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,06
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,9
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;5.086
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;4.845
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;4.705
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,26
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,51
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.170
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;3.954
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;3.801
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,82
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,15
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;8.743
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;8.405
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,13
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.748
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;4.575
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,36
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.995
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;3.830
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,87
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;18.194
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;17.571
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;17.174
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,58
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,39
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;10.588
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;10.225
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;10.029
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,57
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,72
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;7.606
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;7.346
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;7.145
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,58
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,94
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;17.381
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;16.949
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,51
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;10.060
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;9.839
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,8
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;7.321
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;7.110
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,12
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;20.596
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;20.028
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;19.666
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,24
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,48
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;12.509
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;12.178
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;12.001
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,35
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,94
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;8.087
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;7.850
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;7.665
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,07
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,78
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;20.847
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;20.448
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,09
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;12.600
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;12.407
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,47
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;8.247
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;8.041
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,5
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;11.518
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;10.807
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;10.397
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,83
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,27
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;6.880
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;6.449
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;6.220
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,74
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,41
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.638
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;4.358
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;4.177
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,96
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,06
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;12.803
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;12.330
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,31
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;7.657
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;7.392
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,54
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;5.146
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;4.938
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,96
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;10.394
05 Ávila;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;9.962
05 Ávila;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;9.706
05 Ávila;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,84
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,38
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;6.737
05 Ávila;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;6.463
05 Ávila;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;6.318
05 Ávila;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,93
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,78
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.657
05 Ávila;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;3.499
05 Ávila;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;3.388
05 Ávila;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,68
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,64
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;10.352
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;10.053
05 Ávila;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,11
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;6.704
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;6.536
05 Ávila;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,49
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.648
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;3.517
05 Ávila;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,41
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;575
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;533
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;505
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92,7
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;87,83
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;375
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;349
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;334
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,07
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89,07
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;200
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;184
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;171
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85,5
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;501
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;471
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94,01
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;347
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;331
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,39
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;154
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;140
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;90,91
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.496
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;1.423
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;1.386
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,12
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,65
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;900
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;859
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;840
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,44
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,33
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;596
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;564
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;546
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,63
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,61
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.435
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;1.394
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,14
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;860
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;835
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,09
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;575
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;559
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,22
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.775
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;2.687
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;2.631
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,83
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,81
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.765
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;1.708
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;1.675
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,77
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,9
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.010
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;979
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;956
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,93
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,65
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.680
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;2.609
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,35
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.675
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;1.639
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,85
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.005
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;970
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,52
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.327
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;3.231
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;3.170
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,11
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,28
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.175
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;2.118
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;2.087
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,38
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,95
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.152
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;1.113
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;1.083
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,61
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,01
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.298
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;3.228
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,88
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.164
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;2.130
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,43
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.134
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;1.098
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,83
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.221
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;2.088
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;2.014
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,01
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,68
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.522
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;1.429
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;1.382
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,89
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,8
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;699
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;659
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;632
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,28
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,41
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.438
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;2.351
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,43
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.658
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;1.601
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,56
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;780
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;750
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,15
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;40.159
06 Badajoz;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;38.488
06 Badajoz;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;37.467
06 Badajoz;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,84
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,3
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;25.732
06 Badajoz;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;24.741
06 Badajoz;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;24.182
06 Badajoz;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,15
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,98
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;14.427
06 Badajoz;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;13.747
06 Badajoz;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;13.285
06 Badajoz;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,29
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,08
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;39.960
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;38.841
06 Badajoz;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,2
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;25.590
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;24.968
06 Badajoz;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,57
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;14.370
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;13.873
06 Badajoz;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,54
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.165
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;2.935
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;2.799
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92,73
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;88,44
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.908
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1.766
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1.690
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92,56
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;88,57
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.257
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1.169
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1.109
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;88,23
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.837
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;2.703
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,28
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.731
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1.656
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,67
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.106
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1.047
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,67
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;7.821
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;7.475
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;7.279
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,58
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,07
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.626
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;4.427
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;4.321
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,7
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,41
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.195
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;3.048
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;2.958
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,4
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,58
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;7.385
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;7.173
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,13
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.343
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;4.221
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,19
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.042
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;2.952
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,04
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;11.546
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;11.150
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;10.859
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,57
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,05
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;7.291
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;7.077
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;6.930
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,06
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,05
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.255
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;4.073
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;3.929
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,72
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,34
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;11.269
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;10.955
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,21
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;7.032
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;6.873
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,74
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.237
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;4.082
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,34
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;11.303
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;10.984
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;10.797
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,18
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,52
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;7.559
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;7.382
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;7.286
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,66
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96,39
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.744
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;3.602
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;3.511
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,21
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,78
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;11.461
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;11.237
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,05
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;7.665
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;7.549
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,49
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.796
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;3.688
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,15
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;6.324
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;5.944
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;5.733
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,99
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,65
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.348
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;4.089
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;3.955
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,04
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,96
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.976
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1.855
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1.778
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,88
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,98
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;7.008
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;6.773
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,65
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.819
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;4.669
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,89
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.189
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;2.104
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,12
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;97.938
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;93.118
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;90.494
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,08
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,4
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;62.452
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;59.590
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;58.094
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,42
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,02
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;35.486
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;33.528
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;32.400
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,48
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,3
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;99.488
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;96.420
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,92
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;63.334
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;61.563
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,2
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;36.154
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;34.857
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,41
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;6.298
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;5.763
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;5.481
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91,51
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;87,03
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.082
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;3.763
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;3.600
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92,19
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;88,19
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.216
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;2.000
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1.881
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90,25
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84,88
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;5.744
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;5.427
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94,48
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;3.781
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;3.597
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,13
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.963
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1.830
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93,22
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;17.508
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;16.455
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;15.891
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,99
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,76
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;10.559
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;9.958
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;9.649
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,31
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,38
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;6.949
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;6.497
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;6.242
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,5
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,83
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;16.797
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;16.163
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,23
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;10.069
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;9.721
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,54
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;6.728
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;6.442
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,75
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;29.277
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;27.997
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;27.292
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,63
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,22
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;18.650
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;17.909
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;17.522
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,03
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,95
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;10.627
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;10.088
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;9.770
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,93
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,94
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;28.599
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;27.768
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,09
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;18.136
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;17.676
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,46
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;10.463
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;10.092
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,45
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;28.712
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;27.712
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;27.161
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,52
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,6
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;18.704
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;18.090
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;17.769
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,72
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;10.008
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;9.622
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;9.392
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,14
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,84
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;29.445
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;28.785
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,76
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;19.190
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;18.788
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,91
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;10.255
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;9.997
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,48
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;16.143
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;15.191
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;14.669
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,1
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,87
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;10.457
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;9.870
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;9.554
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,39
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,36
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;5.686
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;5.321
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;5.115
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,58
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,96
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;18.903
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;18.277
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,69
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;12.158
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;11.781
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,9
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;6.745
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;6.496
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,31
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;410.792
08 Barcelona;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;389.739
08 Barcelona;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;377.234
08 Barcelona;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,88
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,83
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;256.711
08 Barcelona;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;244.006
08 Barcelona;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;236.699
08 Barcelona;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,05
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,2
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;154.081
08 Barcelona;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;145.733
08 Barcelona;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;140.535
08 Barcelona;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,58
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,21
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;411.087
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;396.949
08 Barcelona;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,56
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;256.633
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;248.332
08 Barcelona;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,77
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;154.454
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;148.617
08 Barcelona;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,22
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;31.673
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;28.549
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;26.754
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90,14
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84,47
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;19.769
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;17.857
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;16.762
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90,33
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;84,79
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;11.904
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;10.692
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;9.992
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;89,82
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;83,94
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;28.393
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;26.451
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,16
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;17.857
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;16.650
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93,24
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;10.536
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;9.801
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93,02
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;73.065
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;68.163
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;65.176
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,29
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89,2
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;43.002
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;40.250
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;38.583
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,6
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89,72
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;30.063
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;27.913
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;26.593
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,85
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;88,46
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;71.017
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;67.651
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,26
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;41.676
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;39.782
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,46
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;29.341
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;27.869
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,98
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;113.110
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;108.071
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;104.996
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,55
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,83
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;70.508
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;67.438
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;65.678
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,65
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,15
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;42.602
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;40.633
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;39.318
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,38
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,29
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;109.119
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;105.685
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,85
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;67.612
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;65.646
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,09
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;41.507
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;40.039
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,46
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;121.724
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;117.930
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;115.568
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,88
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,94
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;77.728
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;75.416
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;74.043
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,03
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,26
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;43.996
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;42.514
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;41.525
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,63
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,38
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;123.844
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;121.103
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,79
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;78.991
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;77.379
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,96
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;44.853
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;43.724
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,48
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;71.220
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;67.026
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;64.740
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,11
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,9
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;45.704
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;43.045
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;41.633
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,18
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,09
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;25.516
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;23.981
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;23.107
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,98
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,56
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;78.714
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;76.059
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,63
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;50.497
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;48.875
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,79
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;28.217
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;27.184
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,34
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;78.976
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;75.560
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;73.109
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,67
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,57
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;46.308
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;44.178
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;42.909
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,4
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,66
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;32.668
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;31.382
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;30.200
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,06
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,45
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;78.788
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;76.069
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,55
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;46.042
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;44.603
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,87
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;32.746
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;31.466
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,09
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.734
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;4.325
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;4.020
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91,36
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84,92
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.890
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2.629
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;2.445
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90,97
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;84,6
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.844
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1.696
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1.575
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;91,97
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85,41
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.399
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;4.048
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92,02
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.714
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;2.491
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;91,78
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.685
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1.557
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,4
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;11.515
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;10.840
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;10.374
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,14
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,09
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;6.539
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;6.135
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;5.910
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,82
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,38
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.976
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;4.705
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;4.464
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,55
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,71
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;10.945
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;10.424
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,24
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;6.223
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;5.956
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,71
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.722
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;4.468
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,62
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;21.446
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;20.703
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;20.104
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,54
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,74
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;12.289
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;11.810
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;11.519
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,1
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,73
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;9.157
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;8.893
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;8.585
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,12
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,75
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;20.333
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;19.679
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,78
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;11.615
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;11.289
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,19
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;8.718
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;8.390
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,24
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;27.263
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;26.584
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;26.046
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,51
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,54
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;15.693
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;15.297
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;15.045
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,48
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,87
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;11.570
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;11.287
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;11.001
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,55
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95,08
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;27.462
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;26.908
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,98
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;15.619
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;15.356
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,32
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;11.843
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;11.552
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,54
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;14.018
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;13.108
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;12.565
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,51
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89,63
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;8.897
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;8.307
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;7.990
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,37
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89,81
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;5.121
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;4.801
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;4.575
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,75
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,34
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;15.649
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;15.010
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,92
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;9.871
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;9.511
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,35
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;5.778
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;5.499
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,17
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;21.358
09 Burgos;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;20.426
09 Burgos;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;19.955
09 Burgos;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,64
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,43
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;13.154
09 Burgos;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;12.599
09 Burgos;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;12.349
09 Burgos;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,78
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,88
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;8.204
09 Burgos;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;7.827
09 Burgos;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;7.606
09 Burgos;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,4
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,71
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;21.210
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;20.671
09 Burgos;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,46
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;13.076
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;12.785
09 Burgos;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,77
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;8.134
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;7.886
09 Burgos;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,95
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.179
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1.067
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1.000
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90,5
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84,82
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;707
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;645
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;606
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91,23
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;85,71
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;472
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;422
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;394
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;89,41
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;83,47
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.061
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;982
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92,55
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;670
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;621
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;92,69
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;391
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;361
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,33
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.042
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;2.894
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;2.800
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,13
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,04
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.735
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;1.651
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;1.599
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,16
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,16
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.307
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1.243
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1.201
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,1
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,89
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.879
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;2.778
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,49
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.635
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;1.579
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,57
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.244
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1.199
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,38
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;5.738
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;5.570
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;5.470
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,07
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,33
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.437
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;3.338
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;3.295
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,12
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,87
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.301
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2.232
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2.175
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,52
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;5.451
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;5.342
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;3.225
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;3.178
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,54
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.226
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2.164
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,21
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;6.836
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;6.637
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;6.537
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,09
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,63
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.239
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;4.132
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;4.083
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,48
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96,32
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.597
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;2.505
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;2.454
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,46
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,49
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;6.889
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;6.767
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,23
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.307
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;4.246
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,58
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.582
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;2.521
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,64
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.563
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;4.258
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;4.148
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,32
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,91
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.036
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;2.833
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;2.766
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,31
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,11
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.527
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1.425
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1.382
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,32
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,5
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.930
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;4.802
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,4
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;3.239
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;3.161
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,59
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.691
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1.641
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,04
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;24.516
10 Cáceres;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;23.553
10 Cáceres;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;22.945
10 Cáceres;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,07
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,59
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;15.265
10 Cáceres;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;14.706
10 Cáceres;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;14.365
10 Cáceres;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,34
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,1
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;9.251
10 Cáceres;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;8.847
10 Cáceres;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;8.580
10 Cáceres;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,63
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,75
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;24.489
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;23.821
10 Cáceres;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,27
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;15.233
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;14.862
10 Cáceres;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,56
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;9.256
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;8.959
10 Cáceres;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,79
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.707
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1.582
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1.514
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92,68
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;88,69
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.021
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;959
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;918
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,93
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89,91
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;686
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;623
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;596
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90,82
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86,88
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.527
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;1.456
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,35
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;938
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;897
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,63
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;589
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;559
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,91
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.347
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;4.176
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;4.060
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,07
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,4
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.497
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;2.411
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;2.360
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,56
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,51
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.850
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1.765
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1.700
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,41
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,89
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.127
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;4.010
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,17
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.379
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;2.323
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,65
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.748
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1.687
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,51
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;6.968
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;6.729
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;6.592
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,57
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,6
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.365
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;4.227
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;4.144
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,84
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,94
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.603
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2.502
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2.448
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,12
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,05
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;6.771
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;6.608
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,59
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.201
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;4.112
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,88
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.570
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2.496
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,12
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;7.241
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;7.036
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;6.894
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,17
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,21
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.627
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;4.507
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;4.430
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,41
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,74
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.614
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;2.529
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;2.464
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,75
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,26
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;7.324
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;7.176
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,98
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.640
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;4.556
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,19
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.684
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;2.620
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,62
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.253
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;4.030
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;3.885
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,76
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,35
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.755
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;2.602
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;2.513
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,45
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,22
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.498
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1.428
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1.372
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,33
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,59
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.740
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;4.571
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,43
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;3.075
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;2.974
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,72
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.665
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1.597
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,92
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;63.836
11 Cádiz;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;60.674
11 Cádiz;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;58.738
11 Cádiz;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,05
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,01
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;39.607
11 Cádiz;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;37.783
11 Cádiz;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;36.699
11 Cádiz;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,39
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,66
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;24.229
11 Cádiz;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;22.891
11 Cádiz;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;22.039
11 Cádiz;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,48
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,96
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;64.044
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;61.841
11 Cádiz;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,56
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;39.691
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;38.454
11 Cádiz;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,88
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;24.353
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;23.387
11 Cádiz;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,03
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.740
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;4.319
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;4.092
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91,12
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86,33
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.765
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2.506
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;2.372
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90,63
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;85,79
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.975
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1.813
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1.720
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;91,8
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;87,09
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.276
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;4.018
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,97
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.514
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;2.362
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93,95
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.762
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1.656
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93,98
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;11.966
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;11.307
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;10.880
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,49
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,92
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;6.825
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;6.494
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;6.280
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,15
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,01
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;5.141
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;4.813
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;4.600
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,62
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,48
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;11.479
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;11.021
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,01
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;6.571
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;6.336
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,42
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.908
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;4.685
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,46
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;19.276
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;18.439
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;17.902
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,66
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,87
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;11.817
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;11.362
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;11.069
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,15
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,67
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;7.459
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;7.077
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;6.833
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,88
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,61
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;18.677
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;18.063
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,71
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;11.396
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;11.050
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,96
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;7.281
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;7.013
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,32
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;18.656
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;17.975
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;17.545
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,35
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,04
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;12.041
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;11.622
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;11.379
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,52
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,5
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;6.615
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;6.353
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;6.166
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,04
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,21
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;19.085
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;18.590
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,41
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;12.207
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;11.941
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,82
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;6.878
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;6.649
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,67
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;9.198
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;8.634
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;8.319
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,87
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,44
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;6.159
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;5.799
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;5.599
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,15
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,91
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.039
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;2.835
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;2.720
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,29
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,5
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;10.527
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;10.149
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,41
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;7.003
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;6.765
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,6
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.524
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;3.384
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,03
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;37.937
39 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;36.449
39 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;35.523
39 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,08
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,64
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;23.174
39 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;22.283
39 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;21.781
39 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,16
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,99
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;14.763
39 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;14.166
39 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;13.742
39 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,96
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,08
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;37.832
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;36.798
39 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,27
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;23.070
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;22.513
39 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,59
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;14.762
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;14.285
39 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,77
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.134
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1.989
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1.882
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,21
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;88,19
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.309
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1.225
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1.167
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,58
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89,15
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;825
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;764
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;715
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,61
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86,67
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.895
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;1.786
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94,25
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.174
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1.113
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94,8
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;721
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;673
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93,34
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;5.530
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;5.271
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;5.123
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,32
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,64
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.162
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;3.008
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;2.921
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,13
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,38
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.368
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;2.263
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;2.202
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,57
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,99
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;5.232
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;5.062
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,75
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.957
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;2.861
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,75
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.275
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;2.201
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,75
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;10.852
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;10.494
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;10.245
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,7
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,41
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;6.610
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;6.404
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;6.280
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,88
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,01
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.242
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;4.090
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;3.965
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,42
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,47
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;10.411
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;10.143
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,43
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;6.337
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;6.203
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,89
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.074
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;3.940
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,71
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;12.211
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;11.907
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;11.702
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,51
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,83
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;7.605
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;7.438
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;7.345
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,8
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96,58
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.606
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;4.469
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;4.357
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,03
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,59
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;12.242
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;12.009
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,1
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;7.612
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;7.500
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,53
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.630
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;4.509
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,39
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;7.210
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;6.788
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;6.571
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,15
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,14
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.488
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;4.208
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;4.068
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,76
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,64
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.722
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;2.580
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;2.503
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,78
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,95
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;8.052
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;7.798
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,85
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.990
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;4.836
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,91
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.062
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;2.962
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,73
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;39.980
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;38.062
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;36.951
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,2
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,42
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;24.457
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;23.328
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;22.703
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,38
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,83
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;15.523
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;14.734
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;14.248
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,92
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,79
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;40.262
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;38.986
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,83
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;24.638
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;23.911
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,05
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;15.624
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;15.075
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,49
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.772
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;2.534
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;2.397
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91,41
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86,47
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.757
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1.624
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1.541
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92,43
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87,71
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.015
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;910
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;856
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;89,66
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84,33
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.540
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;2.375
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,5
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.642
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1.540
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93,79
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;898
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;835
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,98
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;6.617
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;6.228
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;6.032
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,12
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,16
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.817
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;3.588
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;3.483
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,25
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.800
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;2.640
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;2.549
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,29
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,04
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;6.432
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;6.204
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,46
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;3.700
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;3.572
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,54
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.732
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;2.632
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,34
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;11.986
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;11.516
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;11.220
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,08
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,61
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;7.305
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;7.027
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;6.870
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,19
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,05
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.681
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;4.489
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;4.350
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,9
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,93
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;11.562
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;11.239
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,21
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;6.981
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;6.811
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,56
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.581
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;4.428
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,66
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;12.118
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;11.743
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;11.494
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,91
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,85
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;7.529
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;7.315
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;7.172
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,16
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,26
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.589
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;4.428
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;4.322
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,49
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,18
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;12.418
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;12.133
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,7
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;7.770
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;7.601
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,82
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.648
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;4.532
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,5
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;6.487
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;6.041
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;5.808
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,12
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89,53
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.049
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;3.774
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;3.637
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,21
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89,82
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.438
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;2.267
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;2.171
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,99
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,05
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;7.310
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;7.035
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,24
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.545
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;4.387
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,52
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.765
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;2.648
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,77
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;28.383
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;27.304
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;26.522
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,2
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,44
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;18.233
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;17.565
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;17.108
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,34
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,83
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;10.150
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;9.739
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;9.414
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,95
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,75
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;28.354
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;27.476
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,9
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;18.143
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;17.636
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,21
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;10.211
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;9.840
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,37
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.897
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1.790
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1.694
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,36
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89,3
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.200
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1.135
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1.069
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,58
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89,08
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;697
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;655
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;625
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,97
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,67
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.745
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;1.640
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,98
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.109
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1.037
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93,51
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;636
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;603
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,81
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.991
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;4.801
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;4.649
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,19
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,15
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.004
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;2.885
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;2.800
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,04
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,21
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.987
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1.916
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1.849
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,43
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,05
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.765
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;4.601
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,56
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.827
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;2.737
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,82
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.938
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1.864
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,18
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;8.078
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;7.828
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;7.661
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,91
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,84
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;5.104
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;4.966
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;4.883
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,3
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,67
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.974
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2.862
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2.778
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,23
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,41
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;7.846
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;7.650
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,5
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.924
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;4.828
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,05
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.922
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2.822
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,58
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;8.468
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;8.252
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;8.085
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,45
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,48
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;5.571
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;5.444
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;5.355
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,72
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96,12
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.897
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;2.808
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;2.730
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,93
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,24
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;8.526
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;8.343
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,85
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;5.585
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;5.487
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,25
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.941
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;2.856
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,11
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.949
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;4.633
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;4.433
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,61
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89,57
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.354
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;3.135
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;3.001
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,47
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89,48
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.595
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1.498
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1.432
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,92
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,78
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;5.472
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;5.242
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,8
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;3.698
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;3.547
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,92
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.774
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1.695
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,55
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;46.337
14 Córdoba;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;44.405
14 Córdoba;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;43.172
14 Córdoba;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,83
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,17
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;29.516
14 Córdoba;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;28.352
14 Córdoba;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;27.678
14 Córdoba;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,06
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,77
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;16.821
14 Córdoba;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;16.053
14 Córdoba;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;15.494
14 Córdoba;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,43
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,11
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;46.231
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;44.834
14 Córdoba;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,98
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;29.414
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;28.649
14 Córdoba;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,4
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;16.817
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;16.185
14 Córdoba;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,24
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.362
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;3.072
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;2.908
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91,37
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86,5
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.052
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1.864
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1.765
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90,84
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86,01
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.310
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1.208
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1.143
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,21
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;87,25
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.032
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;2.850
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.876
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1.765
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94,08
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.156
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1.085
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93,86
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;8.335
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;7.953
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;7.711
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,42
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,51
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.819
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;4.615
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;4.492
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,77
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,21
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.516
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;3.338
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;3.219
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,94
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,55
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;7.950
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;7.689
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,72
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.602
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;4.471
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,15
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.348
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;3.218
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,12
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;13.198
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;12.768
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;12.473
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,74
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,51
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;8.389
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;8.139
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;7.999
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,02
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,35
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.809
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;4.629
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;4.474
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,26
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,03
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;12.767
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;12.422
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,3
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;8.037
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;7.864
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,85
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.730
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;4.558
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,36
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;13.946
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;13.551
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;13.272
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,17
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,17
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;9.182
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;8.944
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;8.790
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,41
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,73
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.764
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;4.607
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;4.482
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,7
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,08
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;13.992
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;13.688
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,83
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;9.167
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;9.001
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,19
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.825
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;4.687
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,14
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;7.496
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;7.061
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;6.808
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,2
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,82
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;5.074
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;4.790
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;4.632
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,4
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,29
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.422
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;2.271
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;2.176
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,77
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,84
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;8.490
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;8.185
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,41
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;5.732
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;5.548
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,79
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.758
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;2.637
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,61
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;75.797
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;72.866
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;70.970
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,13
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,63
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;44.931
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;43.280
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;42.217
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,33
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,96
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;30.866
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;29.586
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;28.753
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,85
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,15
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;75.663
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;73.572
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,24
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;44.851
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;43.667
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,36
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;30.812
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;29.905
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,06
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.029
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;3.695
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;3.484
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91,71
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86,47
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.361
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2.159
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;2.036
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91,44
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86,23
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.668
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1.536
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1.448
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,09
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86,81
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.663
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;3.439
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,88
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.150
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;2.016
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93,77
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.513
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1.423
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,05
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;11.557
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;11.000
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;10.646
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,18
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,12
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;6.548
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;6.244
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;6.043
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,36
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,29
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;5.009
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;4.756
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;4.603
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,95
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,89
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;10.904
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;10.504
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,33
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;6.193
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;5.964
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,3
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.711
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;4.540
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,37
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;22.204
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;21.528
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;21.058
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,96
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,84
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;13.141
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;12.805
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;12.564
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,44
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,61
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;9.063
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;8.723
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;8.494
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,25
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,72
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;21.095
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;20.608
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,69
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;12.446
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;12.185
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,9
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;8.649
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;8.423
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,39
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;23.831
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;23.275
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;22.893
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,67
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;96,06
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;14.250
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;13.934
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;13.731
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,78
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96,36
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;9.581
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;9.341
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;9.162
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,5
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95,63
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;24.427
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;23.980
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,17
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;14.615
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;14.378
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,38
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;9.812
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;9.602
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,86
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;14.176
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;13.368
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;12.889
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,3
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,92
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;8.631
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;8.138
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;7.843
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,29
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,87
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;5.545
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;5.230
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;5.046
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,32
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;15.574
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;15.041
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,58
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;9.447
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;9.124
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,58
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;6.127
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;5.917
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,57
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;12.784
16 Cuenca;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;12.245
16 Cuenca;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;11.949
16 Cuenca;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,78
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,47
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;8.417
16 Cuenca;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;8.080
16 Cuenca;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;7.924
16 Cuenca;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,14
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.367
16 Cuenca;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;4.165
16 Cuenca;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;4.025
16 Cuenca;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,37
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,17
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;12.739
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;12.405
16 Cuenca;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,38
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;8.383
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;8.201
16 Cuenca;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,83
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.356
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;4.204
16 Cuenca;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,51
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;839
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;790
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;745
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,16
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;88,8
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;543
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;510
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;488
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,92
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89,87
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;296
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;280
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;257
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,59
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86,82
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;776
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;721
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92,91
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;500
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;471
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94,2
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;276
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;250
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;90,58
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.153
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;2.048
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;1.994
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,12
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,61
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.305
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;1.250
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;1.222
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,79
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,64
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;848
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;798
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;772
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,1
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,04
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.038
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;1.976
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,96
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.262
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;1.230
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,46
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;776
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;746
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,13
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.386
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;3.283
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;3.213
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,96
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,89
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.237
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;2.177
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;2.144
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,32
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,84
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.149
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;1.106
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;1.069
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,26
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,04
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.298
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;3.224
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,76
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.151
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;2.115
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,33
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.147
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;1.109
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,69
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.974
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;3.862
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;3.806
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,18
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,77
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.657
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;2.591
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;2.564
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,52
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96,5
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.317
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;1.271
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;1.242
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,51
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,31
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.953
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;3.889
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,38
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.630
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;2.597
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,75
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.323
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;1.292
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,66
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.432
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;2.262
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;2.191
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,01
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,09
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.675
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;1.552
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;1.506
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92,66
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89,91
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;757
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;710
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;685
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,79
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,49
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.674
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;2.595
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,05
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.840
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;1.788
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,17
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;834
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;807
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,76
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;62.346
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;60.088
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;58.532
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,38
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,88
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;39.631
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;38.160
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;37.205
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,29
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,88
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;22.715
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;21.928
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;21.327
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,54
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,89
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;62.420
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;60.667
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,19
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;39.658
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;38.564
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,24
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;22.762
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;22.103
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,1
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.512
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;4.205
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;3.960
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,2
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;87,77
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.106
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2.888
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;2.725
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92,98
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87,73
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.406
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1.317
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1.235
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,67
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;87,84
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.164
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;3.871
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92,96
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.899
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;2.705
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93,31
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.265
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1.166
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,17
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;9.195
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;8.806
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;8.504
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,77
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,49
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;5.755
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;5.513
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;5.333
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,79
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,67
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.440
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;3.293
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;3.171
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,73
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,18
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;9.019
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;8.689
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,34
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;5.672
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;5.469
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,42
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.347
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;3.220
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,21
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;17.761
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;17.329
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;17.008
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,57
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,76
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;11.028
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;10.737
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;10.544
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,36
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,61
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;6.733
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;6.592
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;6.464
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,91
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;96
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;16.706
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;16.345
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,84
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;10.283
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;10.063
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,86
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;6.423
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;6.282
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,8
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;21.139
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;20.675
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;20.359
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,81
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;96,31
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;13.461
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;13.178
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;13.002
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,9
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96,59
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;7.678
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;7.497
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;7.357
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,64
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95,82
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;21.550
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;21.230
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,52
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;13.735
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;13.553
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,67
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;7.815
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;7.677
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;98,23
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;9.739
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;9.073
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;8.701
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,16
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89,34
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;6.281
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;5.844
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;5.601
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,04
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89,17
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.458
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;3.229
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;3.100
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,38
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,65
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;10.981
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;10.532
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,91
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;7.069
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;6.774
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,83
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.912
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;3.758
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,06
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;60.898
17 Girona;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;58.162
17 Girona;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;56.658
17 Girona;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,51
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,04
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;38.492
17 Girona;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;36.883
17 Girona;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;36.005
17 Girona;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,82
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,54
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;22.406
17 Girona;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;21.279
17 Girona;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;20.653
17 Girona;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,97
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,18
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;61.067
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;59.384
17 Girona;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,24
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;38.721
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;37.726
17 Girona;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,43
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;22.346
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;21.658
17 Girona;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,92
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.174
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;3.863
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;3.658
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92,55
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;87,64
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.739
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2.542
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;2.409
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92,81
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87,95
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.435
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1.321
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1.249
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,06
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;87,04
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.876
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;3.670
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94,69
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.579
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;2.447
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94,88
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.297
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1.223
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,29
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;9.840
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;9.327
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;9.029
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,79
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,76
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;5.961
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;5.691
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;5.516
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,47
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,53
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.879
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;3.636
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;3.513
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,74
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,56
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;9.375
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;9.036
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,38
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;5.772
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;5.563
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,38
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.603
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;3.473
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,39
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;17.190
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;16.502
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;16.127
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,82
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;10.916
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;10.513
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;10.305
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,31
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,4
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;6.274
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;5.989
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;5.822
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,46
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,8
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;16.423
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;16.011
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,49
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;10.408
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;10.174
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,75
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;6.015
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;5.837
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,04
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;18.079
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;17.510
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;17.209
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,85
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,19
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;11.420
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;11.085
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;10.926
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,07
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,67
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;6.659
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;6.425
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;6.283
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,49
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,35
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;18.480
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;18.138
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,15
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;11.701
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;11.523
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,48
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;6.779
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;6.615
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,58
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;11.615
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;10.960
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;10.635
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,36
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,56
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;7.456
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;7.052
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;6.849
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,58
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,86
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.159
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;3.908
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;3.786
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,96
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,03
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;12.913
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;12.529
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,03
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;8.261
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;8.019
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,07
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.652
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;4.510
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,95
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;61.596
18 Granada;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;58.710
18 Granada;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;56.794
18 Granada;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,31
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,2
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;38.283
18 Granada;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;36.588
18 Granada;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;35.518
18 Granada;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,57
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,78
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;23.313
18 Granada;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;22.122
18 Granada;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;21.276
18 Granada;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,89
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,26
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;61.872
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;59.625
18 Granada;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,37
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;38.421
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;37.148
18 Granada;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,69
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;23.451
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;22.477
18 Granada;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,85
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.636
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;4.190
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;3.951
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90,38
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85,22
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.847
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2.571
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;2.442
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90,31
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;85,77
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.789
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1.619
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1.509
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90,5
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84,35
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.168
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;3.902
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,62
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.600
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;2.453
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94,35
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.568
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1.449
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,41
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;11.874
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;11.258
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;10.871
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,81
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,55
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;7.032
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;6.677
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;6.479
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,95
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,14
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.842
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;4.581
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;4.392
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,61
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,71
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;11.480
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;11.020
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,99
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;6.710
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;6.461
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,29
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.770
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;4.559
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,58
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;18.017
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;17.308
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;16.781
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,06
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,14
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;11.092
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;10.704
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;10.414
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,5
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,89
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;6.925
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;6.604
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;6.367
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,36
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,94
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;17.604
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;16.983
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,47
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;10.856
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;10.509
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,8
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;6.748
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;6.474
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,94
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;17.635
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;17.069
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;16.652
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,79
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,43
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;11.238
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;10.901
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;10.678
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,02
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;6.397
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;6.168
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;5.974
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,42
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,39
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;18.016
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;17.532
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,31
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;11.431
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;11.175
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,76
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;6.585
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;6.357
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,54
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;9.434
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;8.885
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;8.539
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,18
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,51
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;6.074
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;5.735
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;5.505
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,42
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,63
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.360
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;3.150
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;3.034
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,75
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,3
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;10.604
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;10.188
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,08
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;6.824
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;6.550
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,98
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.780
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;3.638
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,24
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;14.581
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;13.898
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;13.433
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,32
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,13
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;9.472
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;9.039
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;8.785
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,43
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,75
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;5.109
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;4.859
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;4.648
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,11
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,98
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;14.573
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;14.041
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,35
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;9.441
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;9.152
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,94
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;5.132
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;4.889
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,27
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.061
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;967
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;908
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91,14
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85,58
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;685
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;621
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;590
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90,66
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86,13
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;376
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;346
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;318
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,02
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84,57
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;977
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;909
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,04
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;629
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;594
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94,44
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;348
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;315
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;90,52
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.268
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;2.147
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;2.058
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,66
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,74
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.358
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;1.280
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;1.233
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,26
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,8
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;910
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;867
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;825
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,27
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,66
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.167
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;2.063
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,2
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.290
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;1.234
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,66
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;877
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;829
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,53
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.347
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;4.174
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;4.067
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,02
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,56
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.784
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;2.682
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;2.623
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,34
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,22
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.563
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;1.492
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;1.444
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,46
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,39
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.161
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;4.046
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,24
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.664
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;2.602
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,67
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.497
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;1.444
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,46
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.443
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;4.299
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;4.191
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,76
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,33
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.956
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;2.866
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;2.807
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,96
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,96
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.487
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;1.433
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;1.384
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,37
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,07
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.554
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;4.427
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,21
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.998
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;2.928
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,67
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.556
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;1.499
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,34
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.462
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;2.311
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;2.209
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,87
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89,72
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.689
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;1.590
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;1.532
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,14
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,7
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;773
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;721
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;677
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,27
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;87,58
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.714
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;2.596
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,65
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.860
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;1.794
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,45
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;854
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;802
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93,91
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;26.086
21 Huelva;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;24.916
21 Huelva;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;24.151
21 Huelva;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,51
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,58
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;16.308
21 Huelva;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;15.618
21 Huelva;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;15.227
21 Huelva;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,77
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,37
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;9.778
21 Huelva;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;9.298
21 Huelva;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;8.924
21 Huelva;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,09
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,27
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;26.269
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;25.383
21 Huelva;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,63
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;16.366
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;15.910
21 Huelva;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,21
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;9.903
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;9.473
21 Huelva;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,66
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.051
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1.871
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1.776
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91,22
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86,59
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.209
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1.101
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1.062
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91,07
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87,84
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;842
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;770
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;714
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;91,45
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84,8
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.853
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;1.745
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94,17
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.083
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1.038
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,84
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;770
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;707
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;91,82
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.774
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;4.533
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;4.385
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,95
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,85
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.731
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;2.602
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;2.532
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,28
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,71
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.043
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1.931
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1.853
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,52
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,7
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.616
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;4.452
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,45
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.647
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;2.566
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,94
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.969
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1.886
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,78
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;7.853
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;7.552
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;7.347
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,17
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,56
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.852
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;4.674
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;4.572
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,33
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,23
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.001
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2.878
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2.775
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,9
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,47
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;7.604
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;7.361
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,8
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.642
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;4.520
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,37
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.962
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2.841
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,91
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;7.739
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;7.502
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;7.334
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,94
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,77
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;5.065
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;4.927
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;4.830
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,28
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,36
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.674
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;2.575
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;2.504
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,3
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,64
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;7.978
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;7.781
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,53
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;5.200
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;5.095
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,98
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.778
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;2.686
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,69
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.669
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;3.458
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;3.309
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,25
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,19
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.451
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;2.314
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;2.231
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,41
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,02
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.218
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1.144
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1.078
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,92
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;88,51
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.218
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;4.044
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,87
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.794
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;2.691
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,31
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.424
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1.353
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,01
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;14.549
22 Huesca;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;13.944
22 Huesca;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;13.547
22 Huesca;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,84
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,11
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;8.827
22 Huesca;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;8.453
22 Huesca;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;8.247
22 Huesca;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,76
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,43
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;5.722
22 Huesca;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;5.491
22 Huesca;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;5.300
22 Huesca;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,96
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,62
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;14.462
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;14.009
22 Huesca;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,87
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;8.762
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;8.523
22 Huesca;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,27
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;5.700
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;5.486
22 Huesca;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,25
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;829
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;764
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;716
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92,16
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86,37
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;511
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;471
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;442
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92,17
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86,5
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;318
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;293
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;274
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,14
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86,16
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;728
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;667
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;91,62
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;450
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;411
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;91,33
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;278
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;256
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,09
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.178
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;2.078
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;2.013
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,41
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,42
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.218
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;1.153
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;1.121
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,66
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,04
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;960
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;925
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;892
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,35
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,92
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.037
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;1.970
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,71
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.150
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;1.120
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,39
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;887
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;850
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,83
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.990
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;3.863
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;3.781
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,82
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,76
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.415
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;2.339
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;2.291
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,85
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,87
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.575
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;1.524
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;1.490
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,76
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,6
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.850
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;3.757
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,58
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.296
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;2.240
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,56
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.554
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;1.517
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,62
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.534
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;4.412
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;4.330
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,31
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,5
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.768
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;2.695
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;2.659
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,36
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96,06
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.766
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;1.717
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;1.671
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,23
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,62
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.570
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;4.476
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,94
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.790
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;2.747
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,46
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.780
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;1.729
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,13
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.018
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;2.827
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;2.707
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,67
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89,7
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.915
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;1.795
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;1.734
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,73
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,55
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.103
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1.032
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;973
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,56
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;88,21
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.277
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;3.139
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,79
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.076
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;2.005
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,58
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.201
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1.134
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,42
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;35.370
23 Jaén;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;33.812
23 Jaén;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;32.781
23 Jaén;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,6
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,68
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;22.495
23 Jaén;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;21.532
23 Jaén;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;20.963
23 Jaén;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,72
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,19
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;12.875
23 Jaén;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;12.280
23 Jaén;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;11.818
23 Jaén;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,38
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,79
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;35.177
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;34.015
23 Jaén;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,7
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;22.356
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;21.701
23 Jaén;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,07
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;12.821
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;12.314
23 Jaén;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,05
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.767
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;2.520
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;2.386
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91,07
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86,23
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.717
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1.574
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1.489
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91,67
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86,72
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.050
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;946
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;897
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90,1
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85,43
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.435
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;2.287
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,92
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.518
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1.420
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93,54
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;917
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;867
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,55
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;6.660
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;6.361
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;6.161
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,51
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,51
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.858
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;3.682
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;3.584
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,44
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,9
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.802
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;2.679
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;2.577
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,61
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,97
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;6.329
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;6.104
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,44
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;3.674
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;3.558
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,84
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.655
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;2.546
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,89
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;9.840
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;9.496
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;9.233
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,5
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,83
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;6.264
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;6.060
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;5.934
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,74
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,73
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.576
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;3.436
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;3.299
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,09
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,25
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;9.564
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;9.268
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,91
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;6.045
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;5.899
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,58
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.519
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;3.369
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,74
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;10.506
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;10.180
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;9.960
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,9
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,8
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;6.868
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;6.664
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;6.541
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,03
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,24
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.638
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;3.516
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;3.419
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,65
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,98
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;10.549
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;10.309
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,72
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;6.888
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;6.755
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,07
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.661
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;3.554
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,08
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;5.597
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;5.255
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;5.041
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,89
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,07
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.788
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;3.552
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;3.415
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,77
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,15
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.809
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1.703
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1.626
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,14
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,88
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;6.300
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;6.047
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,98
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.231
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;4.069
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,17
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.069
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1.978
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,6
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;28.009
24 León;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
24 León;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;26.897
24 León;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;26.168
24 León;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,03
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,43
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;17.175
24 León;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
24 León;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;16.486
24 León;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;16.088
24 León;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,99
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,67
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;10.834
24 León;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
24 León;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;10.411
24 León;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;10.080
24 León;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,1
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,04
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;27.875
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;27.063
24 León;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
24 León;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
24 León;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,09
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;17.048
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;16.605
24 León;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
24 León;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
24 León;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,4
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;10.827
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;10.458
24 León;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
24 León;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
24 León;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,59
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
24 León;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
24 León;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
24 León;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
24 León;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
24 León;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
24 León;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
24 León;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
24 León;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
24 León;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
24 León;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
24 León;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
24 León;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
24 León;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
24 León;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
24 León;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
24 León;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
24 León;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
24 León;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.584
24 León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1.428
24 León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1.333
24 León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90,15
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84,15
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.007
24 León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;912
24 León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;854
24 León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90,57
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;84,81
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;577
24 León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;516
24 León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;479
24 León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;89,43
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;83,02
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.413
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;1.309
24 León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92,64
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;897
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;835
24 León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93,09
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;516
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;474
24 León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;91,86
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.834
24 León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;3.661
24 León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;3.538
24 León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,49
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,28
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.211
24 León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;2.104
24 León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;2.041
24 León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,16
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,31
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.623
24 León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1.557
24 León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1.497
24 León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,93
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,24
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.628
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;3.486
24 León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,09
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.080
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;2.009
24 León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,59
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.548
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1.477
24 León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,41
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;7.696
24 León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;7.445
24 León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;7.279
24 León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,74
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,58
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.663
24 León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;4.530
24 León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;4.448
24 León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,15
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,39
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.033
24 León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2.915
24 León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2.831
24 León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,11
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,34
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;7.302
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;7.117
24 León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,47
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.396
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;4.295
24 León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,7
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.906
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2.822
24 León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,11
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;8.981
24 León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;8.775
24 León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;8.621
24 León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,71
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,99
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;5.544
24 León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;5.413
24 León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;5.332
24 León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,64
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96,18
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.437
24 León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;3.362
24 León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;3.289
24 León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,82
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95,69
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;8.994
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;8.825
24 León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,12
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;5.562
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;5.478
24 León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,49
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.432
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;3.347
24 León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,52
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;5.914
24 León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;5.588
24 León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;5.397
24 León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,49
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,26
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.750
24 León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;3.527
24 León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;3.413
24 León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,05
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,01
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.164
24 León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;2.061
24 León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1.984
24 León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,24
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,68
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;6.538
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;6.326
24 León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,76
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.113
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;3.988
24 León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,96
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.425
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;2.338
24 León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,41
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;28.527
25 Lleida;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;27.294
25 Lleida;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;26.605
25 Lleida;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,68
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,26
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;17.913
25 Lleida;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;17.165
25 Lleida;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;16.774
25 Lleida;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,82
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,64
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;10.614
25 Lleida;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;10.129
25 Lleida;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;9.831
25 Lleida;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,43
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,62
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;28.290
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;27.503
25 Lleida;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,22
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;17.790
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;17.323
25 Lleida;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,37
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;10.500
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;10.180
25 Lleida;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,95
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.106
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1.910
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1.808
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90,69
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85,85
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.357
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1.228
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1.164
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90,49
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;85,78
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;749
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;682
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;644
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;91,05
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85,98
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.823
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;1.715
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94,08
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.189
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1.119
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94,11
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;634
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;596
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,01
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.312
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;4.085
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;3.957
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,74
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,77
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.555
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;2.432
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;2.362
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,19
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,45
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.757
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1.653
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1.595
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,08
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,78
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.146
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;3.989
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,21
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.475
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;2.382
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,24
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.671
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1.607
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,17
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;7.535
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;7.283
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;7.120
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,66
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,49
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.836
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;4.670
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;4.581
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,57
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,73
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.699
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2.613
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2.539
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,81
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,07
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;7.109
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;6.927
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,44
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.503
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;4.401
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,73
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.606
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2.526
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,93
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;8.691
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;8.457
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;8.310
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,31
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,62
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;5.456
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;5.323
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;5.247
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,56
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96,17
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.235
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;3.134
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;3.063
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,88
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,68
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;8.853
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;8.678
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,02
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;5.607
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;5.510
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,27
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.246
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;3.168
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,6
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;5.883
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;5.559
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;5.410
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,49
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,96
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.709
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;3.512
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;3.420
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,69
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,21
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.174
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;2.047
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1.990
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,16
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,54
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;6.359
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;6.194
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,41
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.016
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;3.911
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,39
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.343
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;2.283
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,44
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;21.674
27 Lugo;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;20.928
27 Lugo;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;20.437
27 Lugo;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,56
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,29
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;13.152
27 Lugo;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;12.695
27 Lugo;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;12.413
27 Lugo;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,53
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,38
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;8.522
27 Lugo;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;8.233
27 Lugo;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;8.024
27 Lugo;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,61
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,16
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;21.601
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;21.070
27 Lugo;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,54
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;13.077
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;12.772
27 Lugo;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,67
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;8.524
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;8.298
27 Lugo;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,35
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.085
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1.007
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;960
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92,81
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;88,48
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;640
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;594
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;575
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92,81
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89,84
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;445
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;413
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;385
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,81
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86,52
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;951
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;906
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,27
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;548
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;528
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,35
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;403
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;378
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93,8
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.273
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;3.145
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;3.064
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,09
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,61
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.902
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;1.837
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;1.797
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,58
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,48
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.371
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1.308
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1.267
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,4
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,41
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.031
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;2.941
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,03
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.772
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;1.724
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,29
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.259
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1.217
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,66
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;6.076
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;5.927
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;5.810
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,55
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,62
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.663
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;3.572
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;3.502
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,52
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,6
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.413
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2.355
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2.308
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,6
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95,65
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;5.966
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;5.839
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,87
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;3.582
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;3.509
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,96
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.384
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2.330
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,73
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;6.924
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;6.767
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;6.661
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,73
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;96,2
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.240
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;4.148
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;4.086
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,83
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96,37
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.684
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;2.619
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;2.575
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,58
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95,94
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;6.878
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;6.769
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,42
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.220
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;4.156
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,48
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.658
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;2.613
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;98,31
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.316
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;4.082
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;3.942
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,58
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,33
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.707
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;2.544
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;2.453
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,98
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,62
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.609
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1.538
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1.489
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,59
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,54
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.775
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;4.615
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,65
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.955
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;2.855
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,62
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.820
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1.760
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,7
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;435.183
28 Madrid;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;412.971
28 Madrid;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;399.251
28 Madrid;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,9
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,74
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;272.288
28 Madrid;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;259.029
28 Madrid;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;251.172
28 Madrid;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,13
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,24
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;162.895
28 Madrid;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;153.942
28 Madrid;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;148.079
28 Madrid;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,5
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,9
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;435.499
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;419.865
28 Madrid;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,41
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;272.099
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;263.114
28 Madrid;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,7
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;163.400
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;156.751
28 Madrid;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,93
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;31.040
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;27.905
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;26.091
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;89,9
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84,06
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;18.504
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;16.681
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;15.595
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90,15
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;84,28
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;12.536
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;11.224
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;10.496
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;89,53
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;83,73
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;27.897
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;25.903
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92,85
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;16.767
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;15.555
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;92,77
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;11.130
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;10.348
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,97
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;77.508
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;72.254
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;69.160
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,22
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89,23
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;45.371
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;42.332
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;40.624
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,3
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89,54
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;32.137
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;29.922
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;28.536
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,11
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;88,79
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;75.344
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;71.799
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,29
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;43.903
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;41.946
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,54
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;31.441
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;29.853
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,95
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;123.254
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;117.878
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;114.330
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,64
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,76
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;76.353
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;73.118
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;71.185
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,76
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,23
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;46.901
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;44.760
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;43.145
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,44
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,99
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;119.480
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;115.499
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,67
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;73.489
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;71.309
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,03
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;45.991
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;44.190
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,08
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;125.020
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;120.615
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;117.764
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,48
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,2
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;80.401
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;77.811
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;76.209
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,78
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,79
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;44.619
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;42.804
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;41.555
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,93
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,13
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;128.010
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;124.729
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,44
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;82.194
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;80.346
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,75
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;45.816
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;44.383
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,87
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;78.361
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;74.319
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;71.906
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,84
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,76
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;51.659
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;49.087
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;47.559
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,02
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,06
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;26.702
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;25.232
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;24.347
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,49
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,18
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;84.768
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;81.935
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,66
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;55.746
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;53.958
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,79
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;29.022
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;27.977
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,4
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;137.849
29 Málaga;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;130.457
29 Málaga;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;125.511
29 Málaga;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,64
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,05
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;84.419
29 Málaga;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;80.167
29 Málaga;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;77.443
29 Málaga;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,96
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,74
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;53.430
29 Málaga;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;50.290
29 Málaga;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;48.068
29 Málaga;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,12
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,96
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;138.689
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;133.121
29 Málaga;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,99
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;84.893
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;81.798
29 Málaga;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,35
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;53.796
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;51.323
29 Málaga;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,4
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;10.591
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;9.601
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;9.008
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90,65
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85,05
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;6.442
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;5.864
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;5.515
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91,03
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;85,61
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.149
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;3.737
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;3.493
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90,07
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84,19
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;9.506
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;8.843
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,03
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;5.880
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;5.481
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93,21
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.626
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;3.362
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,72
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;26.671
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;25.026
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;23.950
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,83
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89,8
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;15.333
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;14.448
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;13.855
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,23
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,36
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;11.338
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;10.578
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;10.095
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,3
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,04
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;25.545
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;24.373
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,41
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;14.672
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;14.032
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,64
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;10.873
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;10.341
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,11
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;41.245
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;39.300
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;37.975
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,28
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,07
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;24.856
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;23.777
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;23.114
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,66
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,99
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;16.389
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;15.523
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;14.861
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,72
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,68
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;40.630
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;39.139
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,33
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;24.370
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;23.597
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,83
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;16.260
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;15.542
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,58
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;38.960
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;37.430
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;36.330
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,07
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,25
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;24.516
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;23.637
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;23.041
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,41
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,98
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;14.444
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;13.793
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;13.289
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,49
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;40.015
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;38.786
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,93
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;25.029
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;24.370
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,37
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;14.986
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;14.416
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,2
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;20.382
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;19.100
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;18.248
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,71
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89,53
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;13.272
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;12.441
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;11.918
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,74
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89,8
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;7.110
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;6.659
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;6.330
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,66
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,03
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;22.993
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;21.980
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,59
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;14.942
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;14.318
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,82
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;8.051
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;7.662
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,17
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;95.443
30 Murcia;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;91.475
30 Murcia;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;87.899
30 Murcia;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,84
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,1
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;59.872
30 Murcia;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;57.475
30 Murcia;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;55.336
30 Murcia;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,42
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;35.571
30 Murcia;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;34.000
30 Murcia;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;32.563
30 Murcia;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,58
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,54
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;95.898
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;91.967
30 Murcia;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,9
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;60.089
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;57.751
30 Murcia;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,11
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;35.809
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;34.216
30 Murcia;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,55
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;7.676
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;7.082
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;6.605
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92,26
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86,05
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.761
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;4.389
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;4.104
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92,19
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86,2
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.915
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;2.693
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;2.501
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,38
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85,8
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;6.973
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;6.475
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92,86
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.338
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;4.046
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93,27
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.635
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;2.429
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,18
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;16.903
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;16.094
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;15.328
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,21
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,68
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;9.949
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;9.499
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;9.087
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,48
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,34
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;6.954
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;6.595
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;6.241
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,84
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,75
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;16.318
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;15.495
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94,96
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;9.623
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;9.171
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,3
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;6.695
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;6.324
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,46
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;26.966
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;26.057
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;25.145
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,63
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,25
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;16.785
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;16.254
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;15.700
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,84
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,54
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;10.181
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;9.803
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;9.445
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,29
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,77
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;26.310
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;25.320
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,24
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;16.295
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;15.700
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,35
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;10.015
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;9.620
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,06
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;28.553
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;27.755
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;26.960
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,21
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,42
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;18.196
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;17.741
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;17.251
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,5
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,81
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;10.357
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;10.014
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;9.709
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,69
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,74
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;28.846
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;27.978
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,99
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;18.376
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;17.851
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,14
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;10.470
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;10.127
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,72
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;15.345
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;14.487
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;13.861
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,41
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,33
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;10.181
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;9.592
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;9.194
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,21
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,31
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;5.164
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;4.895
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;4.667
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,79
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,38
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;17.451
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;16.699
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,69
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;11.457
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;10.983
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,86
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;5.994
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;5.716
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,36
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;42.193
31 Navarra;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;40.141
31 Navarra;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;38.760
31 Navarra;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,14
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,86
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;26.630
31 Navarra;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;25.316
31 Navarra;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;24.468
31 Navarra;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,07
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,88
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;15.563
31 Navarra;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;14.825
31 Navarra;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;14.292
31 Navarra;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,26
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,83
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;41.930
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;40.357
31 Navarra;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,25
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;26.486
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;25.489
31 Navarra;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,24
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;15.444
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;14.868
31 Navarra;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,27
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.132
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;2.830
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;2.646
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90,36
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84,48
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.132
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1.915
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1.785
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;89,82
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;83,72
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.000
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;915
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;861
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;91,5
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86,1
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.843
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;2.626
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92,37
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.961
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1.798
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;91,69
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;882
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;828
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93,88
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;6.624
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;6.223
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;5.956
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,95
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89,92
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.090
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;3.815
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;3.656
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,28
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89,39
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.534
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;2.408
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;2.300
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,03
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,77
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;6.285
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;5.997
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,42
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;3.847
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;3.670
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,4
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.438
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;2.327
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,45
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;11.788
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;11.309
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;10.946
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,94
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,86
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;7.205
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;6.910
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;6.704
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,91
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,05
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.583
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;4.399
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;4.242
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,99
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,56
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;11.177
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;10.779
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,44
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;6.815
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;6.585
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,63
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.362
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;4.194
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,15
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;13.338
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;12.948
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;12.661
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,08
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,92
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;8.502
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;8.266
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;8.097
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,22
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,24
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.836
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;4.682
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;4.564
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,82
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,38
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;13.510
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;13.171
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,49
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;8.627
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;8.419
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,59
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.883
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;4.752
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,32
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;7.311
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;6.831
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;6.551
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,43
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89,6
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.701
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;4.410
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;4.226
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,81
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89,9
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.610
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;2.421
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;2.325
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,76
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,08
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;8.115
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;7.784
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,92
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;5.236
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;5.017
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,82
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.879
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;2.767
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,11
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;19.793
32 Ourense;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;18.960
32 Ourense;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;18.470
32 Ourense;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,79
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,32
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;12.157
32 Ourense;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;11.648
32 Ourense;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;11.373
32 Ourense;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,81
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,55
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;7.636
32 Ourense;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;7.312
32 Ourense;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;7.097
32 Ourense;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,76
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,94
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;19.684
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;19.146
32 Ourense;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,27
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;12.038
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;11.730
32 Ourense;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,44
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;7.646
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;7.416
32 Ourense;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,99
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.082
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;990
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;933
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91,5
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86,23
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;672
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;610
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;580
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90,77
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86,31
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;410
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;380
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;353
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,68
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86,1
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;954
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;894
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,71
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;585
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;552
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94,36
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;369
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;342
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,68
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.087
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;2.924
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;2.830
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,72
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,67
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.777
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;1.676
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;1.624
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,32
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,39
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.310
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1.248
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1.206
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,27
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,06
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.920
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;2.820
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,58
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.671
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;1.614
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,59
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.249
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1.206
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,56
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;5.707
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;5.514
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;5.410
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,62
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,8
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.515
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;3.402
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;3.346
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,79
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,19
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.192
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2.112
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2.064
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,35
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,16
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;5.439
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;5.323
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,87
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;3.322
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;3.259
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,1
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.117
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2.064
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,5
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;6.173
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;6.032
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;5.931
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,72
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;96,08
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.844
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;3.773
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;3.716
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;98,15
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96,67
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.329
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;2.259
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;2.215
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,99
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95,11
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;6.249
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;6.136
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,19
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;3.884
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;3.821
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,38
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.365
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;2.315
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,89
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.744
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;3.500
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;3.366
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,48
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89,9
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.349
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;2.187
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;2.107
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,1
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89,7
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.395
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1.313
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1.259
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,12
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,25
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.122
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;3.973
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,39
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.576
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;2.484
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,43
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.546
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1.489
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,31
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;8.978
34 Palencia;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;8.592
34 Palencia;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;8.373
34 Palencia;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,7
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,26
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;5.652
34 Palencia;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;5.406
34 Palencia;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;5.281
34 Palencia;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,65
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,44
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.326
34 Palencia;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;3.186
34 Palencia;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;3.092
34 Palencia;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,79
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,96
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;8.849
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;8.618
34 Palencia;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,39
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;5.555
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;5.422
34 Palencia;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,61
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.294
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;3.196
34 Palencia;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,02
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;485
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;436
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;412
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;89,9
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84,95
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;311
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;281
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;261
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90,35
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;83,92
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;174
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;155
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;151
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;89,08
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86,78
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;398
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;377
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94,72
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;256
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;240
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93,75
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;142
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;137
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,48
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.220
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;1.162
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;1.126
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,25
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,3
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;733
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;698
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;677
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,23
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,36
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;487
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;464
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;449
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,28
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,2
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.138
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;1.097
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,4
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;685
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;659
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,2
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;453
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;438
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,69
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.351
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;2.281
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;2.236
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,02
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,11
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.418
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;1.371
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;1.352
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,69
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,35
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;933
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;910
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;884
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,53
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,75
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.263
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;2.217
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,97
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.364
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;1.344
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,53
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;899
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;873
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,11
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.863
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;2.782
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;2.736
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,17
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,56
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.803
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;1.756
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;1.731
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,39
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96,01
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.060
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;1.026
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;1.005
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,79
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,81
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.768
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;2.722
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,34
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.714
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;1.687
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,42
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.054
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;1.035
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;98,2
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.059
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;1.931
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;1.863
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,78
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,48
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.387
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;1.300
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;1.260
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,73
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,84
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;672
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;631
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;603
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,9
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,73
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.282
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;2.205
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,63
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.536
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;1.492
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,14
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;746
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;713
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,58
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;72.219
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;68.729
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;66.576
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,17
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,19
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;45.395
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;43.288
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;42.058
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,36
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,65
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;26.824
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;25.441
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;24.518
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,84
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,4
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;72.233
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;69.821
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,66
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;45.293
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;43.925
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,98
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;26.940
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;25.896
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,12
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.800
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;4.320
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;4.067
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84,73
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.934
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2.633
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;2.491
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;89,74
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;84,9
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.866
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1.687
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1.576
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90,41
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84,46
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.283
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;4.014
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,72
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.629
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;2.483
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94,45
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.654
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1.531
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,56
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;13.183
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;12.381
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;11.913
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,92
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,37
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;7.538
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;7.089
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;6.839
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,04
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,73
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;5.645
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;5.292
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;5.074
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,75
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,88
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;12.532
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;11.999
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,75
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;7.164
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;6.880
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,04
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;5.368
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;5.119
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,36
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;20.516
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;19.650
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;19.074
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,78
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,97
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;12.476
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;11.951
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;11.639
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,79
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,29
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;8.040
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;7.699
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;7.435
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,76
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,48
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;19.985
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;19.366
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,9
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;11.967
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;11.631
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,19
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;8.018
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;7.735
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,47
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;21.230
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;20.483
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;20.018
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,48
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,29
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;13.896
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;13.452
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;13.186
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,8
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,89
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;7.334
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;7.031
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;6.832
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,87
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,16
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;21.587
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;21.047
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,5
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;14.050
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;13.737
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,77
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;7.537
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;7.310
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,99
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;12.490
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;11.895
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;11.504
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,24
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,11
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;8.551
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;8.163
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;7.903
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,46
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,42
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.939
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;3.732
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;3.601
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,74
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,42
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;13.846
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;13.395
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,74
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;9.483
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;9.194
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,95
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.363
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;4.201
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,29
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;63.709
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;61.150
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;59.595
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,98
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,54
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;37.942
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;36.486
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;35.666
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,16
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;25.767
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;24.664
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;23.929
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,72
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,87
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;63.553
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;61.854
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,33
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;37.816
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;36.899
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,58
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;25.737
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;24.955
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,96
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.637
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;3.334
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;3.142
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91,67
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86,39
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.174
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2.010
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1.911
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92,46
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87,9
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.463
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1.324
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1.231
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90,5
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84,14
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.209
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;3.004
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,61
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.990
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1.876
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94,27
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.219
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1.128
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,53
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;9.428
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;8.979
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;8.704
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,24
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,32
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;5.354
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;5.116
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;4.978
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,55
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,98
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.074
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;3.863
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;3.726
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,82
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,46
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;8.956
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;8.669
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,8
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;5.065
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;4.926
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,26
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.891
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;3.743
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,2
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;18.581
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;17.985
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;17.608
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,79
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,76
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;10.937
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;10.596
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;10.401
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,88
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,1
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;7.644
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;7.389
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;7.207
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,66
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,28
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;17.705
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;17.312
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,78
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;10.344
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;10.131
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,94
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;7.361
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;7.181
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,55
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;20.509
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;19.949
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;19.614
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,27
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,64
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;12.319
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;12.002
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;11.835
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,43
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96,07
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;8.190
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;7.947
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;7.779
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,03
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,98
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;20.890
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;20.497
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,12
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;12.515
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;12.310
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,36
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;8.375
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;8.187
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,76
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;11.554
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;10.903
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;10.527
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,37
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,11
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;7.158
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;6.762
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;6.541
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,47
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,38
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.396
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;4.141
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;3.986
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,2
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,67
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;12.793
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;12.372
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,71
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;7.902
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;7.656
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,89
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.891
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;4.716
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,42
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;20.508
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;19.593
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;19.057
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,54
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,92
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;12.632
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;12.072
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;11.761
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,57
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,1
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;7.876
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;7.521
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;7.296
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,49
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,64
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;20.423
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;19.790
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,9
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;12.568
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;12.197
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,05
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;7.855
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;7.593
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,66
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.316
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1.190
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1.116
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90,43
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84,8
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;872
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;790
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;750
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90,6
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86,01
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;444
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;400
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;366
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90,09
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;82,43
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.181
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;1.082
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;91,62
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;803
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;738
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;91,91
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;378
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;344
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;91,01
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.915
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;2.762
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;2.660
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,75
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,25
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.670
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;1.586
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;1.531
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,97
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,68
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.245
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1.176
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1.129
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,46
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,68
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.836
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;2.710
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,56
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.633
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;1.571
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,2
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.203
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1.139
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,68
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;5.634
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;5.459
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;5.346
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,89
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,89
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.430
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;3.326
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;3.259
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,97
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,01
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.204
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2.133
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2.087
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,78
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,69
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;5.346
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;5.220
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,64
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;3.206
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;3.130
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,63
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.140
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2.090
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,66
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;6.603
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;6.429
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;6.318
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,36
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,68
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.119
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;4.012
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;3.948
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,4
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,85
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.484
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;2.417
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;2.370
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,3
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95,41
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;6.665
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;6.537
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,08
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.174
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;4.098
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,18
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.491
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;2.439
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,91
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.040
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;3.753
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;3.617
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92,9
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89,53
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.541
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;2.358
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;2.273
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92,8
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89,45
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.499
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1.395
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1.344
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,06
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,66
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.395
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;4.241
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,5
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.752
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;2.660
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,66
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.643
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1.581
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,23
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;20.207
37 Salamanca;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;19.440
37 Salamanca;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;18.956
37 Salamanca;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,2
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,81
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;12.988
37 Salamanca;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;12.498
37 Salamanca;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;12.227
37 Salamanca;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,23
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,14
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;7.219
37 Salamanca;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;6.942
37 Salamanca;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;6.729
37 Salamanca;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,16
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,21
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;20.169
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;19.625
37 Salamanca;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,3
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;12.920
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;12.614
37 Salamanca;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,63
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;7.249
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;7.011
37 Salamanca;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,72
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.180
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1.087
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1.029
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92,12
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;87,2
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;768
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;706
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;675
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91,93
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87,89
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;412
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;381
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;354
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,48
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85,92
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.086
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;1.020
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,92
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;721
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;683
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94,73
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;365
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;337
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,33
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.009
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;2.862
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;2.777
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,11
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,29
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.781
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;1.697
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;1.648
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,28
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,53
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.228
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1.165
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1.129
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,87
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,94
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.833
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;2.737
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,61
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.659
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;1.605
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,75
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.174
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1.132
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,42
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;5.181
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;5.023
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;4.919
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,95
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,94
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.321
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;3.219
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;3.163
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,93
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,24
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.860
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;1.804
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;1.756
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,99
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,41
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.955
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;4.838
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,64
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;3.143
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;3.077
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,9
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.812
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;1.761
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,19
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;6.459
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;6.306
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;6.212
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,63
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;96,18
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.161
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;4.069
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;4.023
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,79
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96,68
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.298
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;2.237
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;2.189
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,35
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95,26
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;6.492
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;6.381
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,29
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.169
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;4.115
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,7
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.323
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;2.266
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,55
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.378
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;4.162
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;4.019
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,07
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,8
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.957
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;2.807
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;2.718
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,93
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,92
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.421
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1.355
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1.301
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,36
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,56
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.803
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;4.649
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,79
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;3.228
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;3.134
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,09
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.575
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1.515
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,19
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;69.293
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;65.710
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;63.392
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,83
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,48
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;41.955
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;39.918
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;38.608
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,14
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,02
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;27.338
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;25.792
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;24.784
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,34
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,66
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;69.039
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;66.448
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,25
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;41.786
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;40.316
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,48
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;27.253
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;26.132
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,89
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.619
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;4.163
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;3.882
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90,13
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84,04
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.704
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2.453
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;2.318
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90,72
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;85,72
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.915
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1.710
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1.564
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;89,3
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;81,67
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.091
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;3.787
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92,57
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.463
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;2.294
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93,14
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.628
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1.493
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;91,71
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;12.423
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;11.671
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;11.192
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,95
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,09
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;6.922
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;6.510
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;6.243
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,05
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,19
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;5.501
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;5.161
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;4.949
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,82
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,97
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;11.816
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;11.285
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,51
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;6.572
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;6.283
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,6
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;5.244
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;5.002
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,39
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;19.862
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;18.896
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;18.249
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,14
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,88
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;11.674
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;11.136
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;10.790
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,39
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,43
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;8.188
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;7.760
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;7.459
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,77
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,1
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;19.142
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;18.437
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,32
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;11.081
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;10.712
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,67
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;8.061
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;7.725
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,83
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;20.209
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;19.400
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;18.903
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,54
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;12.732
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;12.275
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;11.988
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,41
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,16
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;7.477
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;7.125
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;6.915
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,29
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,48
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;20.464
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;19.913
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,31
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;12.897
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;12.572
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,48
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;7.567
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;7.341
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,01
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;12.180
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;11.580
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;11.166
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,07
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,67
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;7.923
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;7.544
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;7.269
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,22
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,75
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.257
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;4.036
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;3.897
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,81
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,54
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;13.526
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;13.026
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,3
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;8.773
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;8.455
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,38
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.753
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;4.571
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,17
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;11.022
40 Segovia;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;10.562
40 Segovia;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;10.261
40 Segovia;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,83
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,1
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;7.149
40 Segovia;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;6.859
40 Segovia;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;6.695
40 Segovia;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,94
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,65
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.873
40 Segovia;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;3.703
40 Segovia;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;3.566
40 Segovia;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,61
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,07
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;10.966
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;10.634
40 Segovia;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,97
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;7.083
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;6.897
40 Segovia;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,37
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.883
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;3.737
40 Segovia;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,24
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;633
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;586
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;556
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92,58
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;87,84
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;426
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;398
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;378
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,43
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;88,73
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;207
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;188
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;178
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90,82
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85,99
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;559
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;521
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,2
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;375
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;350
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93,33
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;184
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;171
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,93
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.556
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;1.480
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;1.422
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,12
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,39
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;949
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;900
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;874
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,84
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,1
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;607
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;580
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;548
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,55
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,28
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.477
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;1.417
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,94
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;899
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;870
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,77
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;578
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;547
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,64
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.849
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;2.750
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;2.685
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,53
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,24
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.806
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;1.741
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;1.717
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,4
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,07
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.043
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;1.009
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;968
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,74
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,81
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.759
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;2.686
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,35
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.731
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;1.701
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,27
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.028
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;985
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,82
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.561
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;3.476
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;3.414
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,61
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,87
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.280
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;2.231
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;2.195
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,85
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96,27
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.281
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;1.245
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;1.219
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,19
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95,16
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.496
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;3.430
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,11
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.228
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;2.192
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,38
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.268
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;1.238
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,63
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.423
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;2.270
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;2.184
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,69
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,14
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.688
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;1.589
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;1.531
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,14
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,7
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;735
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;681
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;653
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,65
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;88,84
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.675
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;2.580
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,45
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.850
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;1.784
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,43
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;825
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;796
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,48
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;113.670
41 Sevilla;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;108.544
41 Sevilla;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;105.213
41 Sevilla;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,49
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,56
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;71.372
41 Sevilla;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;68.428
41 Sevilla;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;66.701
41 Sevilla;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,88
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,46
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;42.298
41 Sevilla;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;40.116
41 Sevilla;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;38.512
41 Sevilla;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,84
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,05
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;113.752
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;109.896
41 Sevilla;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,61
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;71.359
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;69.356
41 Sevilla;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,19
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;42.393
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;40.540
41 Sevilla;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,63
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;9.004
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;8.240
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;7.792
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91,51
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86,54
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;5.325
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;4.883
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;4.639
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91,7
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87,12
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.679
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;3.357
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;3.153
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;91,25
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85,7
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;8.238
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;7.689
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,34
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.915
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;4.630
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94,2
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.323
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;3.059
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,06
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;21.077
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;19.986
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;19.282
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,82
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,48
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;12.175
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;11.553
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;11.198
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,89
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,98
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;8.902
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;8.433
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;8.084
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,73
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,81
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;20.246
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;19.458
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,11
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;11.626
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;11.225
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,55
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;8.620
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;8.233
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,51
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;34.373
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;33.016
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;32.103
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,05
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,4
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;21.463
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;20.730
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;20.288
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,58
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,53
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;12.910
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;12.286
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;11.815
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,17
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,52
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;32.982
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;31.984
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,97
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;20.427
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;19.939
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,61
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;12.555
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;12.045
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,94
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;33.614
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;32.555
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;31.824
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,85
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,67
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;21.951
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;21.343
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;20.983
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,23
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,59
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;11.663
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;11.212
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;10.841
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,13
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,95
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;34.521
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;33.665
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,52
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;22.483
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;22.054
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,09
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;12.038
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;11.611
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,45
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;15.602
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;14.747
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;14.212
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,52
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,09
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;10.458
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;9.919
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;9.593
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,85
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,73
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;5.144
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;4.828
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;4.619
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,86
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,79
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;17.765
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;17.100
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,26
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;11.908
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;11.508
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,64
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;5.857
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;5.592
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,48
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;5.313
42 Soria;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;5.068
42 Soria;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;4.944
42 Soria;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,39
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,05
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.412
42 Soria;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;3.257
42 Soria;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;3.190
42 Soria;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,46
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,49
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.901
42 Soria;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;1.811
42 Soria;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;1.754
42 Soria;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,27
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,27
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;5.236
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;5.102
42 Soria;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,44
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;3.359
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;3.285
42 Soria;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,8
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.877
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;1.817
42 Soria;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,8
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;310
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;283
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;264
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91,29
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85,16
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;200
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;182
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;169
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;84,5
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;110
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;101
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;95
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;91,82
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86,36
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;275
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;255
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92,73
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;183
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;168
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;91,8
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;92
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;87
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,57
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;793
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;760
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;745
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,84
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,95
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;460
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;444
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;435
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,52
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,57
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;333
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;316
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;310
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,89
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,09
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;740
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;721
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,43
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;433
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;422
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,46
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;307
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;299
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,39
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.372
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;1.333
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;1.306
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,16
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,19
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;863
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;837
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;826
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,99
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,71
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;509
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;496
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;480
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,45
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,3
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.322
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;1.294
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,88
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;825
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;811
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,3
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;497
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;483
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,18
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.688
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;1.632
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;1.606
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,68
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,14
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.102
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;1.068
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;1.058
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,91
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96,01
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;586
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;564
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;548
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,25
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,52
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.655
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;1.629
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,43
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.073
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;1.063
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;99,07
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;582
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;566
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,25
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.150
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;1.060
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;1.023
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92,17
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;88,96
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;787
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;726
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;702
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92,25
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89,2
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;363
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;334
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;321
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,01
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;88,43
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.244
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;1.203
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,7
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;845
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;821
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,16
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;399
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;382
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,74
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;52.233
43 Tarragona;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;49.704
43 Tarragona;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;48.147
43 Tarragona;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,16
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,18
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;32.505
43 Tarragona;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;31.014
43 Tarragona;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;30.105
43 Tarragona;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,41
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,62
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;19.728
43 Tarragona;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;18.690
43 Tarragona;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;18.042
43 Tarragona;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,74
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,45
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;52.464
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;50.688
43 Tarragona;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,61
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;32.693
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;31.630
43 Tarragona;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,75
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;19.771
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;19.058
43 Tarragona;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,39
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.121
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;3.759
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;3.538
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91,22
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85,85
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.709
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2.492
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;2.347
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91,99
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86,64
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.412
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1.267
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1.191
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;89,73
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84,35
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.766
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;3.506
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,1
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.508
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;2.331
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;92,94
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.258
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1.175
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93,4
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;8.429
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;7.947
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;7.664
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,28
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,92
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.994
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;4.720
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;4.566
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,51
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,43
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.435
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;3.227
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;3.098
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,94
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,19
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;8.149
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;7.836
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,16
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.873
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;4.693
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,31
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.276
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;3.143
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,94
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;15.021
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;14.426
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;14.017
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,04
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,32
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;9.233
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;8.875
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;8.653
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,12
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,72
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;5.788
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;5.551
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;5.364
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,91
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,67
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;14.466
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;14.013
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,87
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;8.854
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;8.614
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,29
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;5.612
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;5.399
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,2
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;15.784
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;15.275
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;14.935
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,78
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,62
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;9.884
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;9.594
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;9.392
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,07
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,02
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;5.900
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;5.681
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;5.543
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,29
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,95
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;16.178
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;15.795
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,63
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;10.094
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;9.856
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,64
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;6.084
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;5.939
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,62
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;8.878
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;8.297
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;7.993
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,46
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,03
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;5.685
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;5.333
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;5.147
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,81
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,54
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.193
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;2.964
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;2.846
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,83
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,13
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;9.905
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;9.538
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,29
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;6.364
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;6.136
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,42
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.541
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;3.402
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,07
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;8.685
44 Teruel;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;8.317
44 Teruel;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;8.087
44 Teruel;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,76
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,11
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;5.430
44 Teruel;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;5.200
44 Teruel;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;5.069
44 Teruel;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,76
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,35
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.255
44 Teruel;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;3.117
44 Teruel;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;3.018
44 Teruel;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,76
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,72
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;8.632
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;8.376
44 Teruel;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,03
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;5.385
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;5.240
44 Teruel;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,31
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.247
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;3.136
44 Teruel;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,58
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;546
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;493
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;473
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90,29
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86,63
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;359
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;327
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;314
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91,09
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87,47
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;187
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;166
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;159
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;88,77
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85,03
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;491
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;466
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94,91
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;332
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;314
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94,58
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;159
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;152
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,6
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.466
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;1.399
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;1.359
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,43
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,7
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;860
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;817
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;793
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,21
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;606
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;582
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;566
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,04
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,4
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.377
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;1.332
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,73
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;798
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;773
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,87
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;579
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;559
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,55
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.328
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;2.254
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;2.206
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,82
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,76
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.456
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;1.411
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;1.383
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,91
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,99
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;872
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;843
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;823
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,67
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,38
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.242
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;2.186
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,5
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.394
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;1.362
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,7
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;848
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;824
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,17
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.738
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;2.662
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;2.615
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,22
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,51
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.727
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;1.682
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;1.658
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,39
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.011
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;980
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;957
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,93
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,66
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.725
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;2.675
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,17
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.700
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;1.676
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,59
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.025
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;999
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,46
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.607
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;1.509
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;1.434
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,9
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89,23
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.028
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;963
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;921
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,68
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89,59
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;579
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;546
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;513
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,3
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;88,6
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.797
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;1.717
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,55
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.161
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;1.115
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,04
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;636
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;602
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,65
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;45.537
45 Toledo;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;43.631
45 Toledo;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;42.321
45 Toledo;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,81
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,94
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;29.950
45 Toledo;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;28.775
45 Toledo;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;28.046
45 Toledo;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,08
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,64
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;15.587
45 Toledo;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;14.856
45 Toledo;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;14.275
45 Toledo;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,31
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,58
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;45.699
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;44.202
45 Toledo;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,72
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;30.007
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;29.178
45 Toledo;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,24
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;15.692
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;15.024
45 Toledo;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,74
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.107
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;2.857
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;2.695
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91,95
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86,74
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.075
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1.905
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1.815
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91,81
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87,47
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.032
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;952
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;880
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,25
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85,27
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.878
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;2.697
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,71
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.943
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1.835
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94,44
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;935
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;862
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,19
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;7.171
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;6.836
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;6.592
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,33
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,93
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.366
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;4.169
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;4.040
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,49
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,53
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.805
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;2.667
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;2.552
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,08
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,98
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;6.885
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;6.605
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,93
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.181
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;4.042
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,68
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.704
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;2.563
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,79
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;13.409
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;12.945
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;12.585
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,54
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,85
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;8.845
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;8.574
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;8.383
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,94
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,78
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.564
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;4.371
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;4.202
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,77
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,07
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;12.932
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;12.532
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,91
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;8.458
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;8.251
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,55
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.474
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;4.281
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,69
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;14.032
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;13.624
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;13.348
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,09
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,13
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;9.306
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;9.064
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;8.909
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,4
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,73
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;4.726
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;4.560
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;4.439
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,49
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,93
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;14.312
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;13.987
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,73
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;9.502
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;9.315
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,03
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.810
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;4.672
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,13
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;7.818
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;7.369
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;7.101
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,26
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,83
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;5.358
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;5.063
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;4.899
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,49
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,43
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.460
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;2.306
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;2.202
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,74
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,51
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;8.692
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;8.381
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,42
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;5.923
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;5.735
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,83
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.769
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;2.646
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,56
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;188.542
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;179.136
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;173.309
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,01
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,92
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;116.950
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;111.457
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;108.241
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,3
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,55
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;71.592
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;67.679
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;65.068
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,53
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,89
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;189.596
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;182.857
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,45
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;117.660
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;113.919
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,82
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;71.936
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;68.938
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,83
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;14.816
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;13.392
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;12.605
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90,39
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85,08
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;9.137
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;8.286
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;7.842
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90,69
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;85,83
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;5.679
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;5.106
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;4.763
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;89,91
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;83,87
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;13.380
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;12.496
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,39
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;8.401
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;7.885
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93,86
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.979
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;4.611
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,61
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;34.444
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;32.324
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;30.967
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,85
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89,91
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;20.039
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;18.869
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;18.135
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,16
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,5
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;14.405
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;13.455
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;12.832
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,41
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,08
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;33.477
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;31.919
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95,35
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;19.455
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;18.623
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,72
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;14.022
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;13.296
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,82
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;54.991
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;52.722
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;51.221
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,87
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,14
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;33.947
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;32.652
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;31.874
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,19
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,89
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;21.044
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;20.070
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;19.347
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,37
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,94
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;53.736
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;52.003
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,77
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;32.946
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;32.036
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,24
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;20.790
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;19.967
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,04
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;55.667
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;53.869
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;52.711
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,77
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,69
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;35.369
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;34.305
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;33.666
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,99
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,19
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;20.298
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;19.564
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;19.045
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,38
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,83
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;56.961
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;55.602
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,61
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;36.185
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;35.435
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,93
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;20.776
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;20.167
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,07
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;28.624
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;26.829
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;25.805
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,73
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,15
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;18.458
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;17.345
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;16.724
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,97
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,61
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;10.166
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;9.484
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;9.081
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,29
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,33
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;32.042
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;30.837
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,24
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;20.673
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;19.940
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,45
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;11.369
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;10.897
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,85
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;29.786
47 Valladolid;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;28.499
47 Valladolid;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;27.699
47 Valladolid;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,68
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,99
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;18.711
47 Valladolid;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;17.925
47 Valladolid;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;17.487
47 Valladolid;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,8
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,46
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;11.075
47 Valladolid;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;10.574
47 Valladolid;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;10.212
47 Valladolid;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,48
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,21
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;29.528
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;28.624
47 Valladolid;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,94
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;18.522
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;18.020
47 Valladolid;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,29
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;11.006
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;10.604
47 Valladolid;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,35
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.723
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1.558
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1.480
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90,42
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85,9
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.075
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;971
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;925
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90,33
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86,05
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;648
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;587
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;555
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90,59
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85,65
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.544
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;1.435
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92,94
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;969
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;903
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93,19
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;575
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;532
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,52
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.090
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;3.857
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;3.720
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,3
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,95
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.363
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;2.220
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;2.144
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,95
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,73
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.727
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1.637
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1.576
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,79
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,26
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.840
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;3.697
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,28
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.216
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;2.133
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,25
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.624
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1.564
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,31
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;7.937
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;7.644
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;7.464
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,31
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,04
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.902
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;4.731
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;4.648
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,51
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,82
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.035
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2.913
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2.816
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,98
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,78
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;7.521
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;7.323
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,37
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.584
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;4.488
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,91
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.937
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2.835
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,53
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;9.844
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;9.614
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;9.417
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,66
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,66
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;6.249
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;6.128
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;6.030
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;98,06
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96,5
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.595
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;3.486
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;3.387
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,97
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,21
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;9.791
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;9.582
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,87
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;6.258
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;6.150
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,27
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.533
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;3.432
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,14
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;6.192
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;5.826
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;5.618
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,09
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,73
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;4.122
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;3.875
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;3.740
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,01
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,73
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;2.070
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1.951
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1.878
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,25
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,72
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;6.832
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;6.587
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,41
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.495
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;4.346
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,69
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;2.337
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;2.241
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,89
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;11.129
49 Zamora;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;10.722
49 Zamora;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;10.476
49 Zamora;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,34
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,13
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;7.142
49 Zamora;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;6.881
49 Zamora;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;6.753
49 Zamora;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,35
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,55
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.987
49 Zamora;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;3.841
49 Zamora;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;3.723
49 Zamora;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,34
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,38
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;11.085
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;10.808
49 Zamora;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,5
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;7.090
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;6.947
49 Zamora;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,98
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.995
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;3.861
49 Zamora;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,65
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;658
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;607
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;579
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92,25
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;87,99
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;454
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;422
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;403
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92,95
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;88,77
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;204
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;185
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;176
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90,69
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86,27
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;609
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;573
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94,09
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;416
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;394
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94,71
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;193
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;179
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,75
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.590
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;1.513
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;1.476
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,16
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,83
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;971
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;926
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;904
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,37
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,1
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;619
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;587
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;572
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,83
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,41
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.467
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;1.430
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,48
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;904
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;880
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,35
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;563
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;550
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,69
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.885
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;2.805
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;2.745
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,23
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,15
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.814
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;1.763
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;1.745
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,19
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96,2
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.071
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;1.042
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;1.000
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,29
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,37
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.724
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;2.657
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,54
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.697
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;1.678
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,88
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.027
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;979
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,33
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.519
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;3.444
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;3.391
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,87
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;96,36
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.237
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;2.199
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;2.175
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;98,3
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;97,23
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.282
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;1.245
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;1.216
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,11
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,85
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.525
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;3.468
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,38
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.261
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;2.233
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,76
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.264
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;1.235
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,71
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;2.477
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;2.353
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;2.285
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,99
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,25
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.666
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;1.571
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;1.526
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,3
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,6
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;811
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;782
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;759
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,42
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,59
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;2.760
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;2.680
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,1
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.812
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;1.762
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,24
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;948
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;918
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,84
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;57.027
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;54.313
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;52.757
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,24
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,51
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;35.586
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;33.959
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;33.089
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,43
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,98
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;21.441
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;20.354
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;19.668
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,93
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,73
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;56.550
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;54.788
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,88
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;35.287
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;34.293
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,18
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;21.263
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;20.495
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,39
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.934
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;3.531
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;3.340
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;89,76
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84,9
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2.537
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2.283
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;2.173
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;89,99
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;85,65
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.397
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1.248
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1.167
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;89,33
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;83,54
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.478
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;3.247
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93,36
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;2.247
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;2.114
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94,08
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.231
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1.133
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92,04
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;8.896
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;8.411
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;8.114
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,55
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,21
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;5.192
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;4.930
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;4.765
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,95
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91,78
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.704
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;3.481
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;3.349
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93,98
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,42
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;8.456
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;8.153
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,42
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;4.966
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;4.796
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,58
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;3.490
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;3.357
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,19
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;15.641
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;15.038
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;14.690
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,14
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,92
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;9.641
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;9.292
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;9.105
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,38
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,44
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;6.000
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;5.746
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;5.585
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,77
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,08
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;14.794
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;14.399
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,33
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;9.065
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;8.843
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,55
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;5.729
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;5.556
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,98
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;18.115
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;17.594
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;17.236
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,12
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95,15
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;11.469
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;11.146
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;10.949
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97,18
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95,47
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;6.646
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;6.448
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;6.287
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97,02
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,6
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;18.324
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;17.918
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,78
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;11.575
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;11.350
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,06
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;6.749
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;6.568
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,32
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;10.441
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;9.739
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;9.377
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,28
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89,81
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;6.747
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;6.308
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;6.097
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,49
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,37
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;3.694
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;3.431
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;3.280
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,88
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;88,79
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;11.498
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;11.071
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,29
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;7.434
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;7.190
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,72
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;4.064
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;3.881
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,5
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;3.091
51 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;2.942
51 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;2.860
51 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,18
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92,53
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;1.976
51 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;1.880
51 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;1.834
51 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,14
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,81
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.115
51 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;1.062
51 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;1.026
51 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,25
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,02
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;3.046
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;2.955
51 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,01
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;1.952
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;1.901
51 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,39
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.094
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;1.054
51 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,34
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;268
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;239
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;220
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;89,18
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;82,09
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;186
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;163
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;151
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;87,63
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;81,18
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;82
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;76
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;69
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92,68
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84,15
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;211
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;193
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;91,47
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;152
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;140
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;92,11
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;59
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;53
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;89,83
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;596
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;563
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;537
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,46
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,1
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;339
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;320
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;306
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94,4
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,27
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;257
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;243
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;231
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,55
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,88
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;565
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;536
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94,87
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;318
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;302
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94,97
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;247
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;234
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,74
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;804
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;773
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;757
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,14
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,15
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;509
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;491
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;480
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,46
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,3
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;295
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;282
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;277
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,59
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93,9
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;788
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;770
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,72
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;504
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;492
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,62
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;284
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;278
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,89
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;827
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;807
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;799
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97,58
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;96,61
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;546
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;536
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;531
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;98,17
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;97,25
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;281
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;271
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;268
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,44
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95,37
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;845
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;833
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98,58
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;557
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;550
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,74
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;288
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;283
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;98,26
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;596
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;560
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;547
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93,96
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,78
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;396
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;370
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;366
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,43
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,42
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;200
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;190
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;181
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90,5
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;637
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;623
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,8
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;421
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;417
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;99,05
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;216
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;206
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,37
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;4.263
52 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;4.048
52 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;3.907
52 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,96
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91,65
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;3.039
52 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;2.895
52 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;2.808
52 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,26
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,4
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;1.224
52 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;1.153
52 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;1.099
52 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94,2
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,79
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;4.252
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;4.087
52 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,12
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;3.032
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;2.930
52 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,64
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;1.220
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;1.157
52 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94,84
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;407
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;361
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;331
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;88,7
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;81,33
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;255
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;232
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;215
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90,98
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;84,31
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;152
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;129
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;116
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;84,87
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;76,32
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;362
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;329
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;90,88
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;239
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;220
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;92,05
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;123
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;109
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;88,62
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;849
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;801
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;766
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94,35
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90,22
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;548
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;514
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;497
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93,8
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90,69
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;301
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;287
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;269
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,35
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89,37
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;816
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;771
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94,49
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;516
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;492
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95,35
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;300
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;279
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.202
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;1.151
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;1.118
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95,76
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93,01
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;866
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;830
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;809
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95,84
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93,42
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;336
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;321
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;309
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,54
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91,96
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.185
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;1.148
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,88
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;835
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;813
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97,37
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;350
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;335
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95,71
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;1.062
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;1.021
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;1.001
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,14
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94,26
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;794
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;766
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;753
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,47
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94,84
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;268
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;255
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;248
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95,15
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92,54
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;1.062
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;1.038
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97,74
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;802
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;787
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98,13
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;260
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;251
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96,54
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;743
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;714
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;691
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96,1
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;576
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;553
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;534
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96,01
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92,71
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;167
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;161
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;157
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96,41
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94,01
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;827
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;801
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96,86
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;640
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;618
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96,56
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;187
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;183
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97,86
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""